Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.
Export 30 results:
Συντάκτης Τίτλος Τύπος [ Έτος] Φίλτρα: Keyword is Animals and Συντάκτης is Polyzos, Stergios A [Clear All Filters]
GM-CSF as a potential candidate of a vaccine-induced reduction of Helicobacter pylori infection..
Helicobacter. 27(3), e12884.
(2022). Postmenopausal osteoporosis coexisting with other metabolic diseases: Treatment considerations..
Maturitas. 147, 19-25.
(2021). Selenium and selenoprotein P in nonalcoholic fatty liver disease..
Hormones (Athens). 19(1), 61-72.
(2020). Outliers of bone metabolic diseases..
Metabolism. 80, 1-4.
(2018). Pharmacotherapy of type 2 diabetes: An update..
Metabolism. 78, 13-42.
(2018).
(2018). Adipose tissue, obesity and non-alcoholic fatty liver disease..
Minerva Endocrinol. 42(2), 92-108.
(2017). Impact of reactive oxygen species generation on Helicobacter pylori-related extragastric diseases: a hypothesis..
Free Radic Res. 51(1), 73-79.
(2017). The intriguing connections of leptin to hyperparathyroidism..
Endocrine. 57(3), 376-387.
(2017). Nonalcoholic fatty liver disease: Updates on associations with the metabolic syndrome and lipid profile and effects of treatment with PPAR-γ agonists..
Metabolism. 66, 64-68.
(2017). Novel aspects of defensins' involvement in virus-induced autoimmunity in the central nervous system..
Med Hypotheses. 102, 33-36.
(2017). Adiponectin as a target for the treatment of nonalcoholic steatohepatitis with thiazolidinediones: A systematic review..
Metabolism. 65(9), 1297-306.
(2016). Colchicine to decrease inflammation and fibrosis in patients with metabolic dysregulation..
Med Hypotheses. 95, 34.
(2016). Nonalcoholic fatty future disease..
Metabolism. 65(8), 1007-16.
(2016). Periostin on the road to nonalcoholic fatty liver disease..
Endocrine. 51(1), 4-6.
(2016). Investigational parathyroid hormone receptor analogs for the treatment of osteoporosis..
Expert Opin Investig Drugs. 24(2), 145-57.
(2015). Irisin: A true, circulating hormone..
Metabolism. 64(12), 1611-8.
(2015). Leptin in health and disease: facts and expectations at its twentieth anniversary..
Metabolism. 64(1), 5-12.
(2015). Leptin in nonalcoholic fatty liver disease: a narrative review..
Metabolism. 64(1), 60-78.
(2015). Necessity for timely noninvasive diagnosis of nonalcoholic fatty liver disease..
Metabolism. 63(2), 161-7.
(2014). Irisin: a renaissance in metabolism?.
Metabolism. 62(8), 1037-44.
(2013). Leptin's role in lipodystrophic and nonlipodystrophic insulin-resistant and diabetic individuals..
Endocr Rev. 34(3), 377-412.
(2013). Nonalcoholic fatty liver disease: multimodal treatment options for a pathogenetically multiple-hit disease..
J Clin Gastroenterol. 46(4), 272-84.
(2012). A rebuttal to the potential anti-tumour benefit of Helicobacter pylori-induced neutrophil-activating protein..
Cancer Immunol Immunother. 61(3), 445-6; discussion 447-51.
(2012). Sulfated oxysterols as candidates for the treatment of nonalcoholic fatty liver disease..
Metabolism. 61(6), 755-8.
(2012).